Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1281616 | PMC |
http://dx.doi.org/10.1177/014107680109400724 | DOI Listing |
Am J Case Rep
January 2025
Department of General Medicine, Juntendo University Faculty of Medicine, Bunkyo, Tokyo, Japan.
BACKGROUND Mondor's disease (MD), or sclerosing superficial thrombophlebitis of the veins of the anterior thoracic wall, is a rare condition of unknown cause that usually involves the superior epigastric vein, producing a visible and palpable Mondor cord. This report describes a 27-year-old Japanese woman presenting with left chest wall pain due to palpable and visible sclerosing superficial thrombophlebitis. CASE REPORT We present the case of a 27-year-old Japanese woman who presented with 8 days of left chest wall and upper abdominal pain.
View Article and Find Full Text PDFCureus
October 2024
Respiratory Medicine, Iizuka Hospital, Iizuka, JPN.
Perspect Clin Res
July 2024
Department of Community and Family Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Background: The present study aimed to compare the efficacy, safety, and cost-effectiveness of quick penetrating solution (QPS) heparin, QPS diclofenac, and heparin gel in the prevention of superficial thrombophlebitis (ST).
Materials And Methods: This randomized controlled trial was conducted after approval from the Institutional Ethics Committee and registration to Clinical Trial Registry of India. Patients of 18-60 years age, I/II, and who needed venous cannulation for at least 72 h were included in the study.
Radiol Case Rep
January 2025
Department of Radiology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA.
Mondor disease (MD) is a rare, benign condition marked by thrombophlebitis of superficial veins of the breast or anterior chest wall. While it is idiopathic in most cases, it can sometimes occur secondary to an underlying cause. This case report describes a 51-year-old female, who developed MD approximately 7 weeks after undergoing a breast biopsy.
View Article and Find Full Text PDFImportance: Little is known about the safety of midline catheters vs peripherally inserted central catheters (PICCs) for outpatient parenteral antimicrobial therapy (OPAT).
Objective: To compare outcomes from midline catheters vs PICCs for OPAT.
Design, Setting, And Participants: This retrospective cohort study included patients who received antimicrobial therapy through a midline catheter or PICC between January 2017 and November 2023 across 69 Michigan hospitals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!